MS-1020 |
| Katalog-Nr.GC40791 |
MS-1020 ist ein potenter und ATP-kompetitiver JAK3-Inhibitor. MS-1020 hemmt die JAK3/STAT-Signalgebung und induziert Apoptose. MS-1020 fÖrdert den Zelltod. MS-1020 verringert die Expression von Tyrosin-phosphoryliertem STAT3-Spiegel. MS-1020 hat das Potenzial fÜr die Erforschung von Krebsarten mit abweichender JAK3-SignalÜbertragung.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1255516-86-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MS-1020 is a cell-permeable inhibitor of janus kinase 3 (JAK3), strongly inhibiting constitutive autophosphorylation of JAK3 in L540 cells when used at 30-50 μM. It is without effect on other JAK isoforms and several other kinases, including Src, Lyn, Akt, EGFR, and ERK1/2. Through its effects on JAK3, MS-1020 blocks phosphorylation of downstream signal transduction and activators of transcription isoforms, reducing the expression of anti-apoptotic genes, leading to cell death.
Average Rating: 5 (Based on Reviews and 4 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *